Inmune Bio, Inc.

Biotechnology company · Boca Raton, Florida, United States · Nasdaq: INMB

Inmune Bio, Inc. is a biotechnology company headquartered in Boca Raton, Florida, United States. Its earliest recorded incorporation is in 2015. Its shares trade on Nasdaq under the ticker INMB. It has received 1 US government small-business research award (SBIR/STTR) from health agencies, $2 million in total, most recently in 2020. It has reported private securities offerings to the US SEC, most recently $4.7 million sold in a notice filed in 2019.

inmunebio.comProfile compiled from public records. Is this your company? Request a correction or update

Inmune Bio at a glance

Typebiotechnology company
HeadquartersBoca Raton, Florida, United States
Earliest incorporation on record2015
Stock listingNasdaq: INMB
SEC industryBiological Products, (No Diagnostic Substances)
Employees (per SBIR records)3
SEC CIK1711754

What does Inmune Bio do?

US government research funding

1 SBIR/STTR small-business research award from US health agencies, $2 million in total (2020). NIH funding came from the National Institute of Mental Health.

Private fundraising reported to the SEC

2 Form D notices; the most recent reported $4.7 million sold (2019).

Frequently asked questions about Inmune Bio

Where is Inmune Bio headquartered?

Inmune Bio, Inc. is headquartered in Boca Raton, Florida, United States.

What does Inmune Bio do?

Inmune Bio, Inc. is a biotechnology company. Its SEC industry classification is Biological Products, (No Diagnostic Substances).

Is Inmune Bio a public company?

Yes. Inmune Bio, Inc. trades on Nasdaq under the ticker INMB.

When was Inmune Bio founded?

The earliest incorporation on record for Inmune Bio, Inc. is in 2015, according to public company registers.

Similar companies

Need a CRO or CDMO for your next study?

Compare transparent quotes from research and manufacturing partners, then contract once. Free for buyers.

Compare quotes

Sources

Location data: GeoNames (geonames.org), CC BY 4.0.

Last updated 2026-09-23.